Two key studies from ACR/ARP 2020 shed new light on our use of IL-6 inhibitors, including tocilizumab and sarilumab.
Two key studies from ACR/ARP 2020 shed new light on the best approach to tapering therapy during RA remission.
New studies from ACR/ARP 2020 add to our understanding of cardiovascular safety with several RA therapeutics and demonstrate effectiveness of herpes zoster vaccination in patients with RA.
When is a rheumatoid really a rheumatoid, and what are the implications for telemedicine?
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.